Cancer Diagnosis and Prognosis After Guillain–Barré Syndrome: A Population-Based Cohort Study

Figures & data

Figure 1 Standardized incidence ratios for all cancers, except non-melanoma skin cancer, after hospital admission for Guillain–Barré Syndrome, according to sex, age at the time of admission, year of diagnosis, and preexisting diagnoses of infections and autoimmune diseases.

Abbreviations: N, number; O, observed; E, expected; SIR, standardized incidence ratio; CI, confidence interval. Recent infections are defined based on a hospital diagnosis within 6 months before the index date.

Figure 2 Standardized incidence ratios for all cancers, except non-melanoma skin cancer, after hospital admission for Guillain–Barré Syndrome, according to follow-up time.

Abbreviations: N, number; O, observed; E, expected; SIR, standardized incidence ratio; CI, confidence interval.

Figure 3 Standardized incidence ratios for site-specific cancers after hospital admission for Guillain–Barré Syndrome. Only cancers with at least five observations in the first year of follow-up are shown.

Abbreviations: N, number; O, observed; E, expected; SIR, standardized incidence ratio; CI, confidence interval.

Figure 4 Six-month survival of patients diagnosed with cancer within one year after hospital admission for Guillain–Barré Syndrome (GBS) and comparisons, matched by cancer site, sex, age, and year of cancer diagnosis.